drugset / Trial / NCT00653913

Evaluation of Potential for Drug Interaction Between SCH 58235 (Ezetimibe) and Pitavastatin (Study P03962)(COMPLETED)

NCT00653913

Phase 1 Completed 18 enrolled Organon and Co
RandomizedCrossoverOpen-labelTreatment

Summary

This study was designed to evaluate the pharmacokinetic interaction and safety of coadministration of SCH 58235 (ezetimibe) and pitavastatin in healthy Japanese adult male subjects or adult male subjects having no obvious disease other than high cholesterol levels.

Timeline

Start
2004-03
Primary completion
2004-09
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ezetimibe Unknown 10 mg
Comparator Pitavastatin Small molecule 2 mg

Indications

No indication recorded.